High-Content Analysis-Based Sensitivity Prediction and Novel Therapeutics Screening for c-Met-Addicted Glioblastoma.

Cancers (Basel) · 2021 · PMC7864197 · PMID 33498427

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

As abemaciclib has been shown to the penetrate blood brain barrier (BBB) and to have a favorable toxicity profile [ 37 ], expanding clinical indications such as glioblastoma possibly remains highly significant.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.